OpenAlex
PricingAboutJobs
Log inGet started
Author

Ziqin Lin

Institutions: Sun Yat-sen University, Sixth Affiliated Hospital of Sun Yat-sen University, State Key Laboratory of Oncology in South China
Observed institutions: Sun Yat-sen University, Sixth Affiliated Hospital of Sun Yat-sen University, State Key Laboratory of Oncology in South China
OpenAlex ID: A5122836498
KRAS G12V mutation is associated with worse disease-free survival in patients with stage II colorectal cancer: a single-center retrospective study
2026 · Xinrun Huang, You Wu, et al. · BMC Gastroenterology
Cetuximab plus capecitabine every three weeks as first-line maintenance therapy for RAS/BRAF wild-type metastatic colorectal cancer: a phase Ib dose-escalation study
2026 · Xiaoyu Xie, Ziqin Lin, et al. · npj Precision Oncology
PDF
Abstract CT151: CDK4/6 inhibitor dalpiciclib combined with mFOLFOX6 in pretreated metastatic colorectal cancer: Results from a Simon two-stage phase II study
2026 · Xiaoyu Xie, Zhaoliang Yu, et al. · Cancer Research
Efficacy and safety of triweekly cetuximab in combination with capecitabine as first-line maintenance treatment for KRAS/BRAF wild-type metastatic colorectal cancer: A phase Ib dose-escalation study.
2026 · Xiaoyu Xie, Ziqin Lin, et al. · Journal of Clinical Oncology
Works count: 4
Citation count:
H-index:
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms